Rehabilitation
article
Treating scars with Winback
Using Winback TECAR therapy to treat pathological scars
Pathological scars result from problems during the initial vascular and inflammatory phases of healing, during which debridement takes place. During the debridement process, a range of necrotic debris is evacuated, from polynuclear cells that have completed their tasks to fibrin remnants.
The different types of pathological scars are :
Fibrotic scars that result from poor elimination of necrotic debris
Adhesion scars linked to poor elimination of fibrin remnants, which lead to restricted movement between different underlying planes
Retractile scars in which myofibroblasts have persisted beyond the first 21 days, maintaining their contractile power
Hypertrophic scars with an increased proliferation of scar tissue at the scar site
Keloids, which are associated with a proliferation of scar tissue beyond the scar site. In this case, the overreaction of fibroblasts is a contraindication for Winback treatment